Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 65,429 | 68,757 | 62,194 | 69,081 | 58,488 |
| Operating Income | -65,429 | -68,757 | -62,194 | -69,081 | -58,488 |
| Interest Expense | 469 | 468 | 468 | 468 | 465 |
| Other Income | 3,999 | 3,524 | 4,327 | 2,826 | 1,197 |
| Pre-tax Income | -61,899 | -65,701 | -58,335 | -66,723 | -57,756 |
| Net Income Continuous | -61,899 | -65,701 | -58,335 | -66,723 | -57,756 |
| Net Income | $-61,899 | $-65,701 | $-58,335 | $-66,723 | $-57,756 |
| EPS Basic Total Ops | -0.75 | -0.82 | -0.73 | -0.89 | -0.87 |
| EPS Basic Continuous Ops | -0.75 | -0.82 | -0.73 | -0.89 | -0.87 |
| EPS Diluted Total Ops | -0.75 | -0.82 | -0.73 | -0.89 | -0.87 |
| EPS Diluted Continuous Ops | -0.75 | -0.82 | -0.73 | -0.89 | -0.87 |
| EBITDA(a) | $-70,746 | $-67,026 | $-60,521 | $-68,435 | $-56,713 |